»ªÌåÓýappµÇ¼Èë¿Ú

»¶Ó­À´µ½»ªÌåÓýappµÇ¼Èë¿ÚÍøÕ¾£¡
×Éѯµç»°£º18321818584
NEWSÐÂÎŶ¯Ì¬
»ªÌåÓýappµÇ¼Èë¿Ú > ÐÂÎÅÖÐÐÄ > Ñо¿±íÃ÷½¡¿µÉú»î·½Ê½ÓÐÖúÓÚÑÓ»ºË¥ÀÏ

Ñо¿±íÃ÷½¡¿µÉú»î·½Ê½ÓÐÖúÓÚÑÓ»ºË¥ÀÏ

·¢²¼Ê±¼ä£º2022-11-15&²Ô²ú²õ±è;&²Ô²ú²õ±è;&²Ô²ú²õ±è;&²Ô²ú²õ±è;&²Ô²ú²õ±è;&²Ô²ú²õ±è;µã»÷´ÎÊý£º470

Ñо¿±íÃ÷½¡¿µÉú»î·½Ê½ÓÐÖúÓÚÑÓ»ºË¥ÀÏ

    ·¡³¢±õ³§´¡ÊÔ¼ÁºÐÎÒÃǶ¼ÖªµÀ½¡¿µÒûʳ¡¢ÊÊÁ¿Ô˶¯¶ÔÉíÌåÓкô¦¡£Ò»ÏîÑо¿µ÷²é±íÃ÷£¬´Óϸ°ûÀÏ»¯½Ç¶È½øÒ»²½Ö¤Êµ£¬±£³ÖÁ¼ºÃµÄÉú»î·½Ê½£¬È·ÊµÄÜÑÓ»ºË¥ÀÏ¡£½éÉÜ£¬ÈËÌåϸ°ûÄÚµÄȾɫÌåÉÏÓгÆ×÷¶ËÁ£µÄ½á¹¹£¬ËüºÃ±ÈЬ´øÁ½Í··ÀֹĥËðµÄ¡°±£»¤Ã±¡±¡£È˳öÉúʱ£¬È¾É«Ìå¶ËÁ£¶¼ÓÐÒ»¶¨³¤¶È¡£Ëæ×Åϸ°û²»¶Ï·ÖÁѺÍÀÏ»¯£¬¶ËÁ£»áÂýÂý±ä¶Ì¡£Òò´Ë£¬¶ËÁ£³¤¶È±»ÓÃ×÷ÅжÏË¥Àϳ̶ȵÄÖØÒª±êÖ¾¡£
    Ó¢¹úÐÂÒ»ÆÚ¡¶ÁøÒ¶µ¶¡ªÖ×Áö¡·ÔÓÖ¾¿¯µÇÃÀ¹úÑо¿ÈËÔ±µÄÂÛÎÄ˵£¬Ò»ÏîÓÐ35ÃûǰÁÐÏÙ°©»¼Õ߲μӵĸú×ÙÑо¿£¬ÔÚ5ÄêµÄʱ¼äÀÆäÖÐÒ»×éÖ¾Ô¸Õß°´ÒªÇóÍê³ÉÒûʳ¡¢Ô˶¯¡¢Ñ¹Á¦µ÷½ÚµÈµÄ»ý¼«¸Ä±ä£¬ÁíÒ»×é×÷Ϊ¶ÔÕÕ¡£½á¹û·¢ÏÖ£¬»ý¼«×÷³ö¸Ä±äµÄÒ»×éÈ˵ĶËÁ£³¤¶Èƽ¾ùÑÓ³¤ÁËÔ¼0%£¬¶ø¶ÔÕÕ×éÔòƽ¾ùËõ¶ÌÁËÔ¼3%¡£Ñо¿ÈËÔ±½éÉÜ˵£¬ÕâÏîÑо¿Ìáµ½µÄ»ý¼«Éú»î·½Ê½°üÀ¨£º¶à³Ô¸»º¬¹ûÊß¡¢¶¹ÀàºÍ¹ÈÎïµÄʳƷ£¬·¡³¢±õ³§´¡ÊÔ¼ÁºÐ¼õÉÙ̼ˮ»¯ºÏÎïºÍÓÍÖ¬ÉãÈë;¼á³ÖÖеÈÇ¿¶ÈµÄÓÐÑõÔ˶¯£¬ÈçÿÌìÉ¢²½°ëСʱ;Á·Ï°è¤Ù¤»ò½øÐкôÎüѵÁ·¡¢Ú¤ÏëµÈÊæ»ºÑ¹Á¦µÄ»î¶¯;¶¨ÆÚ²Î¼ÓÐÄÀíÒ½Éú×éÖ¯µÄÍÅÌåÐÔ¡°Éç»áÖ§³Ö¡±»î¶¯µÈ¡£

YSRIBIO588    Anti-Myt/FITC  Ó«¹âËØ±ê¼ÇËèÇÊת¼Òò×Ó¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO589    Anti-Phospho-Myt (Ser83) /FITC  Ó«¹âËØ±ê¼ÇÁ×ËữËèÇÊת¼Òò×Ó¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO590    Anti-MyoD/Myf3/FITC  Ó«¹âËØ±ê¼Ç¼¡Ô­µ÷½Úµ°°×¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO59    Anti-MYOG/Myogenin/FITC  Ó«¹âËØ±ê¼Ç¼¡ºìµ°°×¿¹Ìå(¼¡Ï¸°ûÉú³ÉËØ)IgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO592    Anti-RIP3/FITC  Ó«¹âËØ±ê¼ÇÊÜÌå½áºÏ¼¤Ã¸3¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO593    Anti-MYOZ/MYOZ /FITC  Ó«¹âËØ±ê¼ÇMYOZ¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO594    Anti-MYSM/FITC  Ó«¹âËØ±ê¼ÇMYSM¿¹ÌåIgG    Multi-class antibodies    ¹æ¸ñ£º     0.2ml
YSRIBIO595    Anti-CHRNA4/FITC  Ó